Abstracts

Citation

Kristina M. Brooks, Jiajia Wang, Jeremiah D. Momper, David E. Shapiro, Rachael Jeffrey, Renee Browning, Gretchen Buckler, Kevin Knowles, Chelsea Krotje, Brookie M. Best, Mark Mirochnick. Intracellular tenofovir- diphosphate concentrations with tenofovir alafenamide during pregnancy and postpartum in people with HIV: Results from IMPAACT 2026. Presented at: International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs.

Citation

Jeremiah Momper, Hardik Chandasana, Jiajia Wang, Benjamin Johnston, Sarah Bradford, Dwight Yin, Tara Deyampert, Ann Buchanan, Edward P. Acosta, Mark Mirochnick, Kathleen Powis, Diana Clarke. PK and Safety of Chronic Dolutegravir Administration in Neonates Exposed to HIV-1 (IMPAACT 2023). Presented at: CROI 2025; 2025 Mar 11.

Citation

Moherndran Archary, Jorge Pinto, Edmund Capparelli, Edward P. Acosta, S. Y. Amy Cheung, Thomas N. Kakuda, Ellen M. Townley, Jack Moye, Ryan Milligan, Rachel Scheckter, Gaerolwe Masheto, Pradthana Ounchanum, Linda Aurpibul, Lee Fairlie , CRAYON Study Team. Safety and pharmacokinetics of long-acting cabotegravir and rilpivirine in children between 20-40 kg.

Citation

Safa A. Algharbi, Marlon J. Liyanage, Mark Mirochnick, Brookie M. Best, Emily Barr, Alice Stek, Kristina M. Brooks, Sandra Burchett, Kathleen M. Powis, Tim Cressey, Edmund V. Capparelli, Jeremiah D. Momper. Population PK and CYP3A Inhibition Capacity of Ritonavir in Pregnancy: A Model-Based Meta-Analysis.

Citation

Brenda C. Kakayi, Patricia DeMarrais, Kristin Baltrusaitis, Lynda Stranix-Chibanda, Clemensia Nakabiito, Vivian Rexroad, Maxensia Owor, Sufia Dadabhai, Dhayendre Moodley, Friday Saidi, Avy Violari, Gerhard Theron, Takara Leah Stanley, Mary Glenn Fowler. Insulin-like Growth Factors and Stunting in African Infants Exposed to HIV and Uninfected. Presented at: CROI 2025; 2025 Mar 10; San Francisco, CA.

Citation

Danni Wu, Kristin Baltrusaitis, Teacler Nematadzira, Malinda Kaiyo-Utete, Nahida Chakhtoura, Anne Coletti, Katie McCarthy, Chelsea Krotje, Lameck Chinula, Shahin Lockman, Lynda Stranix-Chibanda, IMPAACT 2010 (VESTED) Study Team. Impact of Dolutegravir and Efavirenz on Maternal Mental Health: Depression, Sleep, and Anxiety Outcomes in the IMPAACT 2010 Study. Presented at: CROI 2025; 2025 Mar 10.

Citation

Dorothy E. Dow, Jennifer Libous, Ponego L. Ponatshego, Gaerolwe Masheto, Tisungane Mvalo, Chipiliro Payesa, Janice Buckley, Lynda Stranix-Chibanda, Teacler G. Nematadzira, Tichaona Vhembo, Andi Ace, Meredith Warshaw, Ellen Townley, Sonia Lee, Susannah Allison, Olga Varechtchouk, Geri Donenberg, IMPAACT 2016 Study Team. High levels of mental distress among youth with HIV in Southern Africa: A description of enrollment into IMPAACT 2016, a randomized controlled trial of a peer-led, group-based mental health intervention. Presented at: IAS 2025; 2025 Jul 15.

Citation

Petina Musara, Lynda Stranix-Chibanda, Peter Slutzker, Juliane Etima, Rebecca Nabukenya, Florence Mathebula, Linly Seyama, Mary Nyasha Tichareva, Otilia Munaiwa, Tambudzai Mutasa, Emily Brown, Hans M.L. Spiegel, Deborah Kacanek, Benjamin Chi, K. Rivet Amico, IMPAACT 2009 Study Team. Factors influencing adherence to daily oral PrEP during pregnancy and postpartum: Qualitative findings from Malawi, South Africa, Uganda and Zimbabwe. Presented at: IAS 2025; 2025 Jul 15.

Citation

Lynda Stranix-Chibanda, Violet Korutaro, Michael Whitton, Elizea Horne, Deborah Kacanek, Teacler G. Nematadzira, Clemensia Nakabiito, Benjamin Chi, James F. Rooney, Benjamin Johnston, K. Rivet Amico, Vitumbiko D. Mandiwa, Sharon Huang, Peter Anderson. Infant safety following exposure to maternal TDF/FTC for HIV prevention in utero and through breastmilk: IMPAACT 2009.

Citation

Pauline Howell, Yuanxi Zou, Anthony Garcia-Prats, Grace Montepiedra, Lisa Aaron, Joanna Moreira, Jerry Nedelman, Elin Svensson, Antonio Lombardi, Maria Beumont, Eugene Sun, Sharon Nachman, Anneke Hesseling, Ethel Weld. IMPAACT 2034: Phase 1 Study of the pharmacokinetics (PK), safety/tolerability and acceptability of a single dose of pretomanid in female children with rifampicin-resistant TB (RR-TB). Presented at: The Union World Conference on Lung Health; 2025 Nov 19.